Home/Aramis Biosciences/David Lacey

DL

David Lacey

Chief Operating Officer

Aramis Biosciences

Therapeutic Areas

Ophthalmology Immunology

Aramis Biosciences Pipeline

Drug	Indication	Phase
A197	Dry Eye Disease	Phase 2
Preclinical Programs	Other Immuno-Inflammatory Ocular Disease	Preclinical

Leadership Team at Aramis Biosciences

David S. Tierney, MD

President and Chief Executive Officer

Ken Mandell, MD, PhD

Chief Medical Officer

Reza Dana, MD, MPH, MSc

Scientific Co-Founder

Sunil Chauhan, DVM, PhD

Scientific Co-Founder

View full Aramis Biosciences profile